These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

938 related articles for article (PubMed ID: 9881643)

  • 41. Co-chaperone potentiation of vitamin D receptor-mediated transactivation: a role for Bcl2-associated athanogene-1 as an intracellular-binding protein for 1,25-dihydroxyvitamin D3.
    Chun RF; Gacad M; Nguyen L; Hewison M; Adams JS
    J Mol Endocrinol; 2007 Aug; 39(2):81-9. PubMed ID: 17693608
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potent antiproliferative effects of 25-hydroxy-16-ene-23-yne-vitamin D₃ that resists the catalytic activity of both CYP27B1 and CYP24A1.
    Rhieu SY; Annalora AJ; LaPorta E; Welsh J; Itoh T; Yamamoto K; Sakaki T; Chen TC; Uskokovic MR; Reddy GS
    J Cell Biochem; 2014 Aug; 115(8):1392-402. PubMed ID: 24535953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
    Jung SJ; Lee YY; Pakkala S; de Vos S; Elstner E; Norman AW; Green J; Uskokovic M; Koeffler HP
    Leuk Res; 1994 Jun; 18(6):453-63. PubMed ID: 8207963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor.
    Molnár F; Sigüeiro R; Sato Y; Araujo C; Schuster I; Antony P; Peluso J; Muller C; Mouriño A; Moras D; Rochel N
    PLoS One; 2011 Mar; 6(3):e18124. PubMed ID: 21483824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of a vitamin D3-response element that overlaps a unique inverted TATA box in the rat bone sialoprotein gene.
    Kim RH; Li JJ; Ogata Y; Yamauchi M; Freedman LP; Sodek J
    Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):219-26. PubMed ID: 8761475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3.
    Thummel KE; Brimer C; Yasuda K; Thottassery J; Senn T; Lin Y; Ishizuka H; Kharasch E; Schuetz J; Schuetz E
    Mol Pharmacol; 2001 Dec; 60(6):1399-406. PubMed ID: 11723248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.
    Chen TC; Holick MF; Lokeshwar BL; Burnstein KL; Schwartz GG
    Recent Results Cancer Res; 2003; 164():273-88. PubMed ID: 12899529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium.
    Healy KD; Zella JB; Prahl JM; DeLuca HF
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9733-7. PubMed ID: 12900504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.
    Bula CM; Bishop JE; Ishizuka S; Norman AW
    Mol Endocrinol; 2000 Nov; 14(11):1788-96. PubMed ID: 11075812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
    Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L
    J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Calcitriol regulates the expression of the genes encoding the three key vitamin D3 hydroxylases and the drug-metabolizing enzyme CYP3A4 in the human fetal intestine.
    Theodoropoulos C; Demers C; Delvin E; Ménard D; Gascon-Barré M
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):489-99. PubMed ID: 12641633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
    Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of chromatin organization of vitamin D target genes.
    Carlberg C; Dunlop TW
    Anticancer Res; 2006; 26(4A):2637-45. PubMed ID: 16886674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Consequences of vitamin D receptor regulation for the 1,25-dihydroxyvitamin D3-induced 24-hydroxylase activity in osteoblast-like cells: initiation of the C24-oxidation pathway.
    Staal A; van den Bemd GJ; Birkenhäger JC; Pols HA; van Leeuwen JP
    Bone; 1997 Mar; 20(3):237-43. PubMed ID: 9071474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancement of VDR-mediated transcription by phosphorylation: correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex.
    Barletta F; Freedman LP; Christakos S
    Mol Endocrinol; 2002 Feb; 16(2):301-14. PubMed ID: 11818502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid.
    Kane KF; Langman MJ; Williams GR
    Cancer Res; 1996 Feb; 56(3):623-32. PubMed ID: 8564982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of rat cytochrome P450C24 (CYP24) gene expression. Evidence for functional cooperation of Ras-activated Ets transcription factors with the vitamin D receptor in 1,25-dihydroxyvitamin D(3)-mediated induction.
    Dwivedi PP; Omdahl JL; Kola I; Hume DA; May BK
    J Biol Chem; 2000 Jan; 275(1):47-55. PubMed ID: 10617584
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
    Harant H; Spinner D; Reddy GS; Lindley IJ
    J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
    Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G
    Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
    Norman AW; Zhou JY; Henry HL; Uskokovic MR; Koeffler HP
    Cancer Res; 1990 Nov; 50(21):6857-64. PubMed ID: 2208153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.